Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Pemetrexed MeSH Descriptor Data 2026


MeSH Heading
Pemetrexed
Tree Number(s)
D03.633.100.759.758.399.454.650
D12.125.067.625.525
D12.125.119.409.525
Unique ID
D000068437
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068437
Scope Note
A guanine-derived ANTINEOPLASTIC AGENT that functions as a NUCLEIC ACID SYNTHESIS INHIBITOR through its binding to, and inhibition of, THYMIDYLATE SYNTHASE.
Entry Term(s)
Alimta
LY 231,514
LY 231514
LY-231,514
LY-231514
LY231514
MTA
N-(4-(2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid
Pemetrexed Disodium
Pharm Action
Antineoplastic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Nucleic Acid Synthesis Inhibitors
Registry Numbers
04Q9AIZ7NO
0
2PKU919BA9
Related Numbers
137281-23-3
2PKU919BA9
CAS Type 1 Name
L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-
Public MeSH Note
2016; PEMETREXED was indexed under GLUTAMATES 1994-2015, and under GUANINE 1994-2015
History Note
2016 (1994)
Date Introduced
2016/01/01
Last Updated
2016/05/31
Pemetrexed Preferred
LY 231514 Narrower
Alimta Narrower
Pemetrexed Disodium Narrower
page delivered in 0.129s